MEdical Treatment in Idiopathic Ventricular Fibrillation Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 218 participants.
Also called NCT07405229
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 218 participants
- Sponsor
- Registry
-
NCT07405229 -
2018-001683-37
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Recruiting
Technical summary
Registry record NCT07405229. Randomized; single masking; primary purpose treatment. Start 2018-05-01 (actual); primary completion 2032-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- MEdical Treatment in Idiopathic Ventricular Fibrillation Patients
- Acronym
- RIME-IVF
- Condition
- Idiopathic Ventricular Fibrillation
- Condition
- Cardiac Arrest, Out-Of-Hospital
- Intervention (Drug)
- Beta-blocker treatment group
- Lead sponsor
- Bo Gregers Winkel
- Collaborator
- Novo Nordisk Foundation
- Collaborator
- Danish Heart Foundation
Record details
- Record id
cardio:ct-nct07405229- Content hash
14f5aba98cd4a624d5b05208515fa91e6b4eead1019a4a6d435fec735b96337c